Clinical Trials Directory

Trials / Conditions / Invasive Fungal Disease

Invasive Fungal Disease

18 registered clinical trials studyying Invasive Fungal Disease — 7 currently recruiting.

StatusTrialSponsorPhase
RecruitingImmunomonitoring of Mold Invasive Infections
NCT06285188
Assistance Publique - Hôpitaux de Paris—
RecruitingLiposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD（ Breakthrough Invasive Fungal Disease） in Pa
NCT07135778
Institute of Hematology & Blood Diseases Hospital, China—
Not Yet RecruitingA Clinical Study on the Efficacy and Safety of ABCD in the Treatment of Patients With Invasive Fungal Disease
NCT06376201
Nanfang Hospital, Southern Medical UniversityPhase 4
Enrolling By InvitationL-AmB_ Retrospective mUlticenter Study on Mycosis prOphylaxis
NCT06640296
Istituto Giannina Gaslini—
Enrolling By InvitationPosaconazole Tablet As Primary Prophylaxis of HSCT Patients with Gastrointestinal GVHD
NCT06698211
Institute of Hematology & Blood Diseases Hospital, China—
CompletedCresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi
NCT05630976
PfizerPhase 4
UnknownLFD of Aspergillus Antigen in Paediatrics
NCT05569824
St George's University Hospitals NHS Foundation Trust—
UnknownTo Evaluate the Efficacy and Safety of ABCD in the Treatment of IFD
NCT05116059
Peking Union Medical College Hospital—
RecruitingEfficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease
NCT06819410
Sichuan Provincial People's Hospital—
CompletedStudy of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in A
NCT04368559
Mundipharma Research LimitedPhase 3
CompletedDe-escalation - Antifungal Treatment Immunocompromised Patients
NCT03774316
University Hospital, Lille—
CompletedSingle Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China
NCT03577509
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 1
CompletedEvaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
NCT03262584
Karius, Inc.—
CompletedAssessing Diagnostic Methods for Invasive Fungal Disease in Lung Transplant Recipients
NCT06654076
Guangzhou Institute of Respiratory Disease—
CompletedHepatosplenic CANdidiasis : PETscan and Immune Response Analysis
NCT01916057
Assistance Publique - Hôpitaux de ParisN/A
CompletedPrevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leu
NCT01259713
Gilead SciencesPhase 3
UnknownMicafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplant
NCT01135589
Asan Medical CenterPhase 4
RecruitingFungiScope - A Global Emerging Fungal Infection Registry
NCT01731353
University of Cologne—